Status: Recruiting
Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
The goal of this pilot clinical trial is to test the safety and preliminary performance of the ZetaFuse Bone Graft in patient requiring fusion of the C3-C7 vertebral bones due to pain or loss of neurological function. Participants will be treated with ZetaFuse during surgical intervention to reduce pain and the loss of neurological function.
Participants needed: 10
Trial details
Age: 22-75Biological sex: AllType: InterventionalSponsor: Zetagen Therapeutics, IncUpdated: Apr 24, 2025Locations: 2
Eligibility criteria
Age 22 to 75 years (inclusive) at the time of enrollment. [+18]
A cervical spinal condition other than symptomatic cervical degenerative disc di... [+26]